Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,95 USD | -0,13% | -11,37% | -20,97% |
Vakgebied
Aantal werknemers: 587
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Antibody-based Therapies
100,0
%
| 1 616 | 100,0 % | 86 | 100,0 % | -94,67% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 616 | 100,0 % | 86 | 100,0 % | -94,67% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Sung Lee
DFI | Director of Finance/CFO | 53 | 27-03-23 |
Jennifer Towne
CTO | Chief Tech/Sci/R&D Officer | - | 06/11 |
Aine M. Hanly
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-03-21 |
George Scangos
BRD | Director/Board Member | 76 | 01-01-17 |
Richard Lepke
IRC | Investor Relations Contact | - | 01/01 |
Sasha Ellis
PRN | Corporate Officer/Principal | - | 10-07-23 |
Lynne Krummen
PRN | Corporate Officer/Principal | - | 01-01-18 |
Corporate Officer/Principal | 73 | - | |
Jeff Calcagno
PRN | Corporate Officer/Principal | - | 15-05-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Charles Sigal
BRD | Director/Board Member | 72 | 02-07-20 |
Robert Perez
BRD | Director/Board Member | 59 | 01-01-17 |
Robert More
BRD | Director/Board Member | 56 | 01-09-16 |
Phillip Sharp
BRD | Director/Board Member | 79 | 01-01-17 |
Robert Nelsen
FOU | Founder | 60 | 07-04-16 |
Vicki Sato
CHM | Chairman | 75 | 01-12-16 |
George Scangos
BRD | Director/Board Member | 76 | 01-01-17 |
Director/Board Member | 48 | 01-09-19 | |
Janet Napolitano
BRD | Director/Board Member | 65 | 28-08-20 |
Chief Executive Officer | 56 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 135 032 268 | 115 816 259 ( 85,77 %) | 0 | 85,77 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,97% | 1,07 mld. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |